ASL

argininosuccinate lyase

Basic information

Region (hg38): 7:66075800-66094697

Links

ENSG00000126522NCBI:435OMIM:608310HGNC:746Uniprot:P04424AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • argininosuccinic aciduria (Definitive), mode of inheritance: AR
  • argininosuccinic aciduria (Definitive), mode of inheritance: AR
  • argininosuccinic aciduria (Strong), mode of inheritance: AR
  • argininosuccinic aciduria (Definitive), mode of inheritance: AR
  • argininosuccinic aciduria (Supportive), mode of inheritance: AR
  • argininosuccinic aciduria (Definitive), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Argininosuccinic aciduriaARBiochemical; PharmacogenomicDietary and medical therapy (eg, with low-protein diet supplemented with arginine), may be beneficial, and special care to prevent/treat acute metabolic decompensation (eg, with IV glucose and ammonia-reducing agents) may be effective; Certain agents (such as enflurane, an anesthetic agent) should be avoided due to reports of adverse reactionsBiochemical; Dermatologic; Neurologic13503250; 5836520; 84150; 2263616; 1897577; 1594374; 9504797; 12408190; 12384776; 17326097; 22541557; 20236848; 19635676; 22541557; 22841516; 23040521; 25135652

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the ASL gene.

  • Argininosuccinate_lyase_deficiency (821 variants)
  • not_provided (94 variants)
  • not_specified (60 variants)
  • Inborn_genetic_diseases (36 variants)
  • ASL-related_disorder (12 variants)
  • Neurodevelopmental_disorder (3 variants)
  • Autism (1 variants)
  • Congenital_myasthenic_syndrome_4C (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the ASL gene is commonly pathogenic or not. These statistics are base on transcript: NM_000000048.4. Only rare variants are included in the table.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
12
clinvar
234
clinvar
2
clinvar
248
missense
16
clinvar
113
clinvar
114
clinvar
9
clinvar
1
clinvar
253
nonsense
16
clinvar
16
clinvar
1
clinvar
33
start loss
1
1
frameshift
22
clinvar
28
clinvar
50
splice donor/acceptor (+/-2bp)
15
clinvar
28
clinvar
1
clinvar
1
clinvar
45
Total 69 186 128 244 3

Highest pathogenic variant AF is 0.0018317379

Loading clinvar variants...

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
ASLprotein_codingprotein_codingENST00000304874 1617761
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
8.57e-100.8991256780661257440.000262
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.7492472820.8750.00001953011
Missense in Polyphen78107.790.723651152
Synonymous-1.371341151.160.00000822908
Loss of Function1.831929.80.6380.00000168303

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0001500.000150
Ashkenazi Jewish0.0001990.000198
East Asian0.0003830.000381
Finnish0.0002000.000185
European (Non-Finnish)0.0003600.000352
Middle Eastern0.0003830.000381
South Asian0.0002630.000261
Other0.0001630.000163

dbNSFP

Source: dbNSFP

Disease
DISEASE: Argininosuccinic aciduria (ARGINSA) [MIM:207900]: An autosomal recessive disorder of the urea cycle. The disease is characterized by mental and physical retardation, liver enlargement, skin lesions, dry and brittle hair showing trichorrhexis nodosa microscopically and fluorescing red, convulsions, and episodic unconsciousness. {ECO:0000269|PubMed:12408190, ECO:0000269|PubMed:1705937, ECO:0000269|PubMed:17326097, ECO:0000269|PubMed:19703900, ECO:0000269|PubMed:2263616, ECO:0000269|PubMed:24166829}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Pathway
Alanine, aspartate and glutamate metabolism - Homo sapiens (human);Arginine biosynthesis - Homo sapiens (human);Argininemia;Hyperornithinemia with gyrate atrophy (HOGA);Creatine deficiency, guanidinoacetate methyltransferase deficiency;L-arginine:glycine amidinotransferase deficiency;Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome];Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency);Citrullinemia Type I;Carbamoyl Phosphate Synthetase Deficiency;Argininosuccinic Aciduria;Hypoacetylaspartia;Urea Cycle;Aspartate Metabolism;Prolinemia Type II;Prolidase Deficiency (PD);Ornithine Transcarbamylase Deficiency (OTC Deficiency);Arginine and Proline Metabolism;Hyperprolinemia Type I;Hyperprolinemia Type II;Ornithine Aminotransferase Deficiency (OAT Deficiency);Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency);Canavan Disease;Alanine and aspartate metabolism;Urea cycle and metabolism of amino groups;Citrate cycle;Alanine Aspartate Asparagine metabolism;Metabolism of polyamines;Metabolism of amino acids and derivatives;Metabolism;citrulline-nitric oxide cycle;urea cycle;Arginine Proline metabolism;Urea cycle (Consensus)

Recessive Scores

pRec
0.454

Intolerance Scores

loftool
0.0497
rvis_EVS
-0.98
rvis_percentile_EVS
8.85

Haploinsufficiency Scores

pHI
0.0865
hipred
N
hipred_score
0.112
ghis
0.460

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.964

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Asl
Phenotype
endocrine/exocrine gland phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); muscle phenotype; renal/urinary system phenotype; immune system phenotype; homeostasis/metabolism phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); normal phenotype;

Gene ontology

Biological process
urea cycle;locomotory behavior;post-embryonic development;ammonia assimilation cycle;arginine biosynthetic process via ornithine
Cellular component
cytoplasm;cytosol;extracellular exosome
Molecular function
argininosuccinate lyase activity;protein binding;identical protein binding